Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07379333RecruitingPhase 3
Testing a new drug for type 2 diabetes when metformin and dapagliflozin aren't enough
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
Gyeonggi-doAges 19 years+ - NCT07371065Enrolling by invitationPhase 1
Testing a new drug's safety in healthy adults
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
ShanghaiAges 18–45 - NCT07377994Enrolling by invitation
Gut health and immunity study with a probiotic in healthy adults
This trial tests a probiotic supplement containing Bacillus coagulans to see if it improves gut health and immune function in healthy adults. If you are generally healthy and not taking certain medications or supplements, you may be able to join.
Bangalore, KarnatakaAges 18–50 - NCT07371338RecruitingPhase 1
Testing a new drug for advanced Parkinson's
This trial tests an investigational drug called IPS101A in people with advanced Parkinson's disease. It aims to see if the drug is safe and how well it works when standard treatments are no longer enough.
SeoulAges 50–80 - NCT07377942Enrolling by invitation
Probiotic study for gut and immune health in healthy adults
This study tests a probiotic (a type of good bacteria) called Bacillus subtilis to see how it affects digestion and the immune system in healthy adults. It involves taking the product, giving stool samples, and visiting the clinic for checkups.
Bangalore, KarnatakaAges 18–50 - NCT07374224RecruitingPhase 1
Testing how other drugs affect a new leukemia tablet
This study looks at how two common medicines, itraconazole and rifampin, change the levels of a new drug called Rocbrutinib in healthy volunteers. The results will help doctors understand how to use Rocbrutinib safely in future patients.
Beijing, Beijing MunicipalityAges 18–45 - NCT07370909RecruitingPhase 3
Oral LW402 for moderate-to-severe eczema
This trial tests an oral pill called LW402 for people with moderate-to-severe atopic dermatitis (eczema). It aims to see if the drug is safe and effective at reducing skin symptoms.
BeijingAges 18–75 - NCT07378098RecruitingPhase 3
Study of KLH-2109 for uterine fibroids with heavy bleeding
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
SeoulAges 19 years+ - NCT07371455RecruitingPhase 1
LWP779 safety trial for healthy volunteers
This trial tests a new oral medication called LWP779 in healthy adults to see if it is safe and how the body processes it. It helps determine the right dose for future studies.
AdelaideAges 18–65 - NCT07379216Recruiting
Vitamin C and glutathione drink for skin health
This study tests a liquid supplement containing vitamin C and glutathione to see if it benefits skin health. It may be a good fit if you are a healthy adult looking to improve your skin without using other skin products during the study.
Pingtung CityAges 18–65 - NCT07376642RecruitingEarly Phase 1
Testing IMV101 for relapsed B-cell lymphoma
This study tests an experimental drug called IMV101 for people with certain types of B-cell non-Hodgkin lymphoma that have come back or not responded to other treatments. It aims to see if the drug is safe and if it can shrink tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07377175RecruitingPhase 1
Safety study of BSY001 in healthy adults
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
HangzhouAges 18–50 - NCT07379151Recruiting
Long-term protection from a meningococcal vaccine
This study checks whether the MenFive™ vaccine still protects against meningococcal disease more than five years after vaccination. It aims to see how long the immune response lasts.
BamakoAges 7–36 - NCT06756542Recruiting
AI to improve family talks in intensive care
This trial tests if artificial intelligence can help improve conversations between families and doctors in the intensive care unit. It may make these talks clearer and more supportive for you and your loved one.
Rotterdam, South HollandAges 18 years+ - NCT07367282RecruitingPhase 4
Faricimab for newly diagnosed wet age-related macular degeneration
This study tests if faricimab, an injectable eye medication, can improve vision in people with a newly diagnosed form of wet age-related macular degeneration (AMD). It is for patients who have not yet received treatment for this condition.
SeongnamAges 50 years+ - NCT07369700Enrolling by invitation
Mobile health tool for post-C-section checkups in rural Rwanda
This study tests a mobile health tool (used with a community health worker) to improve recovery checkups after a C-section. It may help women in rural areas get better follow-up care.
Kirehe, KireheAges 14 years+ - NCT07368348Recruiting
Nasal splint vs. flap for CSF leak repair
This trial compares two surgical techniques to repair a cerebrospinal fluid leak (a leak of the fluid around your brain) through the nose. It is for people who have leaks on both sides and have specific conditions in their nasal passage that might make the repair more complex.
Kafr Elsheikh, KafrelsheikhAges 18–70 - NCT07363850Recruiting
Group Gaming Intervention for Problem Gaming Behavior
This study tests whether group gaming activities can help people whose gaming is causing problems — but who do not have a full gaming addiction. Participants will take part in group sessions and complete assessments to see if the approach reduces harmful gaming.
Shanghai, Shanghai MunicipalityAges 12–18 - NCT07365566Recruiting
Pain and sleep behavior disorder study
This study looks at pain in people with a sleep condition called idiopathic REM sleep behavior disorder (iRBD), where people act out their dreams. It also includes a group of people with narcolepsy who have similar sleep issues. The goal is to understand how pain relates to these conditions.
ToulouseAges 18 years+ - NCT07363772Recruiting
Mixed reality CPR training for adults
This trial tests whether mixed reality (a blend of real and virtual worlds) can teach cardiopulmonary resuscitation (CPR) to adults. It may help people who haven't taken a CPR class in the last year learn this lifesaving skill in a new way.
Seoul, Nowon-guAges 18–50 - NCT07363278Recruiting
Study of a new device for atrial fibrillation ablation
This study looks at how often silent brain lesions happen after a new type of heart procedure for atrial fibrillation (an irregular heartbeat). The procedure uses a device called the Varipulse catheter to help fix the heart's rhythm.
Seoul, Jongro-kuAges 19 years+ - NCT07364734Recruiting
Study of hard-to-treat Crohn's disease
This study looks at people with Crohn's disease that is hard to treat. It aims to understand the disease better and see how well current treatments work.
Guangzhou, GuangdongAges 18–65 - NCT07363538Recruiting
Comparing heart surgery methods for newborns with complex heart defects
This trial tests new surgical strategies for newborns with certain complex heart conditions. It aims to see which techniques lead to better recovery and quality of life in the first year after surgery.
Beijing, Beijing MunicipalityAges Up to 1 week - NCT07366424Recruiting
Testing new shoes to prevent falls in seniors
This trial is testing if special shoes called 'CHUT OTONOM®' can improve walking and reduce fall risk in older adults who have fallen before. It may help you find better balance and confidence.
LilleAges 65 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.